Corbus (NASDAQ: CRBP) COO receives RSU and stock option grants in 2026
Rhea-AI Filing Summary
Corbus Pharmaceuticals Holdings, Inc. reported an equity compensation grant to its Chief Operating Officer, Ian Hodgson. On January 14, 2026, he received 28,365 restricted stock units (RSUs), which will be settled in common shares. These RSUs vest 25% on each of the first four anniversaries beginning January 14, 2027, with a provision for partial accelerated vesting if his service is terminated by the company without cause after the first vesting date.
On the same date, he was also granted 85,095 stock options with a $8.26 exercise price under the 2024 Equity Compensation Plan. Twenty‑five percent of this option vests on January 14, 2027, and the remaining 75% vests in equal monthly installments over 36 months starting February 14, 2027. Following these grants, he beneficially owned 54,342 shares of common stock, which include 53,108 unvested RSUs subject to their respective vesting schedules, and 85,095 options.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock options (right to buy) | 85,095 | $0.00 | -- |
| Grant/Award | Common Stock, par value $0.0001 per share | 28,365 | $0.00 | -- |
Footnotes (1)
- On January 14, 2026, the Reporting Person was granted 28,365 restricted stock units ("RSUs"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth anniversary beginning on January 14, 2027. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a pro rata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service. This amount includes 53,108 unvested RSUs subject to each grant's vesting schedule as previously reported. The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on January 14, 2027, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 14, 2027.
FAQ
What insider transactions were reported in this Corbus (CRBP) Form 4?
The filing reports that Chief Operating Officer Ian Hodgson was granted 28,365 RSUs and 85,095 stock options on January 14, 2026 as part of his equity compensation.
How do the 28,365 RSUs granted to the Corbus (CRBP) COO vest?
The 28,365 RSUs vest in four equal installments of 25% each year, on the first, second, third and fourth anniversaries beginning on January 14, 2027, with a pro rata acceleration feature if his service is terminated by the company without cause after the first vesting date.
What are the key terms of the 85,095 stock options granted by Corbus (CRBP)?
The 85,095 stock options have a $8.26 exercise price. 25% vests on January 14, 2027, and the remaining 75% vests in equal monthly installments over 36 months starting on February 14, 2027, under the 2024 Equity Compensation Plan.
What triggers accelerated vesting of the Corbus (CRBP) COO’s RSUs?
If the COO’s service is terminated by the company without cause after the first vesting date, a pro rata portion of the RSUs scheduled to vest on the next vesting date will accelerate based on completed months of service since the most recent vesting date.